A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
Comparative randomized, single dose, two-way crossover open-label study to determine the
bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham
Egypt,LLC affiliated co. to GalaxoSmithKline ) and Biodroxil 1 gm Film Coated tablets (Kahira
Pharm &Chem .Ind. Co . for Novartis Pharma ) after a single oral dose administration of each
to healthy adults under fasting conditions.